Pacer Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.82M | Sell |
92,516
-34,978
| -27% | -$1.07M | 0.01% | 886 |
|
2025
Q1 | $3.44M | Sell |
127,494
-464,507
| -78% | -$12.5M | 0.01% | 767 |
|
2024
Q4 | $21.2M | Buy |
592,001
+47,745
| +9% | +$1.71M | 0.05% | 316 |
|
2024
Q3 | $20.6M | Buy |
544,256
+76,904
| +16% | +$2.92M | 0.04% | 317 |
|
2024
Q2 | $21.1M | Buy |
467,352
+58,597
| +14% | +$2.65M | 0.05% | 302 |
|
2024
Q1 | $19.8M | Buy |
408,755
+71,384
| +21% | +$3.46M | 0.05% | 322 |
|
2023
Q4 | $18.1M | Buy |
337,371
+145,373
| +76% | +$7.79M | 0.05% | 311 |
|
2023
Q3 | $11.3M | Buy |
191,998
+59,736
| +45% | +$3.5M | 0.04% | 308 |
|
2023
Q2 | $8.34M | Sell |
132,262
-3,071
| -2% | -$194K | 0.03% | 432 |
|
2023
Q1 | $8.51M | Buy |
135,333
+37,214
| +38% | +$2.34M | 0.04% | 452 |
|
2022
Q4 | $5.22M | Buy |
98,119
+33,496
| +52% | +$1.78M | 0.03% | 426 |
|
2022
Q3 | $3.62M | Sell |
64,623
-747
| -1% | -$41.9K | 0.03% | 387 |
|
2022
Q2 | $4.73M | Buy |
65,370
+16,084
| +33% | +$1.16M | 0.04% | 372 |
|
2022
Q1 | $3.92M | Buy |
49,286
+9,522
| +24% | +$757K | 0.03% | 469 |
|
2021
Q4 | $4.02M | Buy |
39,764
+8,603
| +28% | +$871K | 0.04% | 542 |
|
2021
Q3 | $2.87M | Buy |
+31,161
| New | +$2.87M | 0.04% | 582 |
|
2021
Q2 | – | Sell |
-15,899
| Closed | -$1.55M | – | 1560 |
|
2021
Q1 | $1.55M | Buy |
15,899
+10,408
| +190% | +$1.02M | 0.03% | 595 |
|
2020
Q4 | $423K | Buy |
5,491
+1,909
| +53% | +$147K | 0.01% | 1035 |
|
2020
Q3 | $264K | Buy |
3,582
+937
| +35% | +$69.1K | 0.01% | 1143 |
|
2020
Q2 | $194K | Buy |
2,645
+531
| +25% | +$38.9K | ﹤0.01% | 807 |
|
2020
Q1 | $145K | Sell |
2,114
-2,450
| -54% | -$168K | ﹤0.01% | 466 |
|
2019
Q4 | $359K | Sell |
4,564
-1,379
| -23% | -$108K | 0.02% | 858 |
|
2019
Q3 | $406K | Buy |
+5,943
| New | +$406K | 0.01% | 1030 |
|